OneMedNet Corp financial data

Symbol
ONMD, ONMDW on Nasdaq
Location
Surrey, United Kingdom
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 14 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 18% % 97%
Debt-to-equity -123% % -11%
Return On Equity 20% % -69%
Return On Assets -87% % 86%
Operating Margin -1866% %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 51,005,205 shares 81%
Common Stock, Shares, Outstanding 49,725,274 shares 78%
Entity Public Float $9,700,000 USD
Common Stock, Value, Issued $2,000 USD 0%
Weighted Average Number of Shares Outstanding, Basic 52,618,031 shares 80%
Weighted Average Number of Shares Outstanding, Diluted 52,618,031 shares 80%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $495,000 USD 25%
Revenue from Contract with Customer, Excluding Assessed Tax $495,000 USD -47%
Cost of Revenue $1,208,000 USD -0.16%
Research and Development Expense $1,394,000 USD -14%
Selling and Marketing Expense $1,059,000 USD 15%
General and Administrative Expense $6,070,000 USD 1.9%
Operating Income (Loss) $9,236,000 USD -5.2%
Nonoperating Income (Expense) $7,204,000 USD 437%
Net Income (Loss) Attributable to Parent $2,034,000 USD 80%
Earnings Per Share, Basic 0 USD/shares -103%
Earnings Per Share, Diluted 0 USD/shares -103%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $149,000 USD -92%
Accounts Receivable, after Allowance for Credit Loss, Current $582,000 USD 824%
Assets, Current $1,446,000 USD -66%
Property, Plant and Equipment, Net $60,000 USD -29%
Assets $1,506,000 USD -66%
Liabilities, Current $5,005,000 USD -73%
Other Liabilities, Noncurrent $440,000 USD 1471%
Liabilities $5,445,000 USD -71%
Retained Earnings (Accumulated Deficit) $101,230,000 USD -2%
Stockholders' Equity Attributable to Parent $3,939,000 USD 72%
Liabilities and Equity $1,506,000 USD -66%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $1,948,000 USD -26%
Net Cash Provided by (Used in) Financing Activities $1,680,000 USD 92%
Net Cash Provided by (Used in) Investing Activities $1,920,000 USD
Common Stock, Shares Authorized 100,000,000 shares 0%
Common Stock, Shares, Issued 49,913,019 shares 77%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $28,000 USD -122%
Interest Paid, Excluding Capitalized Interest, Operating Activities $5,000 USD
Deferred Tax Assets, Valuation Allowance $9,551,000 USD 23%
Deferred Tax Assets, Gross $9,734,000 USD 25%
Payments to Acquire Property, Plant, and Equipment $5,000 USD -17%
Property, Plant and Equipment, Gross $324,000 USD 5.5%
Deferred Tax Assets, Operating Loss Carryforwards $9,092,000 USD 23%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 1,000,000 shares 0%
Unrecognized Tax Benefits $0 USD
Additional Paid in Capital $97,818,000 USD 14%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization $12,000 USD 9.1%
Deferred Tax Assets, Net of Valuation Allowance $183,000 USD 2950%
Share-based Payment Arrangement, Expense $728,000 USD 53%
Interest Expense $14,000 USD
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%